Institut Paoli Calmette

Marseille 13273

0 studies enrolling now · 6 studies all time

What they study most

Advanced Malignant Solid Tumors, Breast Cancer, Breast Cancer Metastatic, Chronic Myelomonocytic Leukemia (CMML), Gastrointestinal Stromal Tumors, Myelodysplastic Syndrome (MDS)/AML, Non-small Cell Lung Cancer (NSCLC), Paroxysmal Nocturnal Hemoglobinuria, Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors — Running, not enrolling
• Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML — Stopped early
• MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer. — Completed
• Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) — Stopped early
• Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer — Completed